EyePoint Pharmaceuticals (EYPT) Stock Chart & Stock Price History $8.02 +0.41 (+5.39%) (As of 12/17/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends EyePoint Pharmaceuticals Stock Price Performance 5 Day Performance+7.51%1 Month Performance-6.53%3 Month Performance-9.99%6 Month Performance-7.71%Year-To-Date Performance-65.30%1 Year Performance-57.68% Receive EYPT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for EyePoint Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now EYPT Stock Chart for Wednesday, December, 18, 2024 EYPT Chart by TradingView EyePoint Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization12/17/2024$7.61$8.02+5.39%$8.21$7.54585,731 shs$547.37 million12/16/2024$7.46$7.61+2.01%$7.65$7.21720,552 shs$519.39 million12/13/2024$7.94$7.46-6.05%$8.07$7.44767,905 shs$509.15 million12/12/2024$8.25$7.94-3.76%$8.23$7.71871,336 shs$541.91 million12/11/2024$8.46$8.25-2.48%$8.50$8.03501,703 shs$563.06 million12/10/2024$8.85$8.46-4.41%$9.00$8.211.58 million shs$577.40 million Get the Latest News and Ratings for EYPT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for EyePoint Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 12/09/2024$8.71$8.85+1.61%$9.23$8.82585,084 shs$604.01 million12/06/2024$8.16$8.71+6.74%$8.97$8.20660,476 shs$594.46 million12/05/2024$8.49$8.16-3.89%$8.55$8.10623,734 shs$556.92 million12/04/2024$8.37$8.49+1.49%$8.56$8.32647,361 shs$579.44 million12/03/2024$8.76$8.37-4.51%$8.88$8.34788,345 shs$570.91 million12/02/2024$8.85$8.76-1.02%$8.88$8.60886,161 shs$597.87 million11/29/2024$9.05$8.85-2.21%$9.18$8.76377,182 shs$604.01 million11/28/2024$9.05$9.05$9.23$8.95537,931 shs$617.66 million11/27/2024$9.00$9.05+0.56%$9.23$8.95537,931 shs$617.66 million11/26/2024$9.23$9.00-2.49%$9.50$8.97637,931 shs$614.26 million11/25/2024$8.95$9.23+3.13%$9.59$9.13708,115 shs$629.96 million11/22/2024$8.35$8.95+7.19%$9.32$8.201.10 million shs$610.84 million11/21/2024$8.95$8.35-6.70%$9.06$8.252.48 million shs$569.89 million11/20/2024$9.21$8.95-2.82%$9.15$8.701.56 million shs$610.84 million11/19/2024$8.58$9.21+7.34%$9.40$8.25873,511 shs$628.58 million11/18/2024$9.17$8.58-6.43%$9.31$8.561.28 million shs$585.59 million Related Companies TRNS Stock Price Chart CTKB Stock Price Chart LAB Stock Price Chart AEHR Stock Price Chart QTRX Stock Price Chart SENS Stock Price Chart NAUT Stock Price Chart QSI Stock Price Chart FEIM Stock Price Chart KEQU Stock Price Chart Receive EYPT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for EyePoint Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:EYPT) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | Sponsored2025’s #1 Trump TradeAll the Energy You Need to Power Your Entire Life... Could Fit Inside This Single Soda Can. Three Companies...The Oxford Club | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored50-year Wall Street legend: “Sell this tech stock NOW”Something very strange is happening to U.S. stocks following President Trump's victory... And this could s...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding EyePoint Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share EyePoint Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
